Search

everythinglearnresearchcommunity

for

Search:↓

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Some alternative medicine treatments might work for skin conditions, but their effectiveness and safety differ a lot.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Belimumab effectively controls SLE disease activity and reduces steroid use.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

Biologics for severe asthma have known side effects, but some new risks need more study.

The herbal extract was found to effectively reduce and prevent hair loss without any side effects.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

Hair follicles prevent NK cell attacks to avoid hair loss.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

Leflunomide is more likely to help treat alopecia areata than cause it.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.